Stay updated on XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa
Sign up to get notified when there's something new on the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page.

Latest updates to the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page
- Check7 days agoChange DetectedAdded a government funding notice about potential delays and updated page revision to v3.4.1 (replacing v3.4.0); these are minor, site-wide notices that do not affect the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check14 days agoChange DetectedAdded a 'Show glossary' option and new QC-related labels (Last Update Submitted that Met QC Criteria, Revision: v3.4.0) while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3, indicating a minor version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a consolidated Locations section with study sites in North Carolina, Oregon, and Texas. Also updated the page revision to v3.3.3.SummaryDifference0.5%

- Check78 days agoChange DetectedThe page's revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check85 days agoChange DetectedThe government funding status notice was removed from the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa
Enter your email address, and we'll notify you when there's something new on the XLRP Clinical Trial: Evaluating Patients with X-linked Retinitis Pigmentosa page.